Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

J.M. Smucker Company (NY: SJM )

113.30 -0.59 (-0.52%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about J.M. Smucker Company

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
How To Earn $500 A Month From J.M. Smucker Stock After Strong Earnings
J.M. Smucker Company (NYSE: SJM) reported better-than-expected earnings for its second quarter on Tuesday. 
Via Benzinga
Goldman Sachs Maintains Sell Rating On J.M. Smucker: Analyst Highlights Challenges Despite EPS Beat
Goldman Sachs analyst Jason English reiterated a Sell rating on J.M. 
Via Benzinga
The J.M. Smucker Company (NYSE: SJM) Making Surprising Moves in Tuesday Session
Via Investor Brand Network
Magnificent Seven See Profit Taking, Moody's Downgrades China Credit Outlook
To gain an edge, this is what you need to know today. 
Via Benzinga
US Stocks Down; JM Smucker Posts Upbeat Earnings
U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.23% to 36,120.88 while the NASDAQ fell... 
Via Benzinga
Topics Stocks
Exposures US Equities
J.M. Smucker's Earnings Twist: Sales Dip But Profits Soar - What's Cooking?
J.M. 
Via Benzinga
Preview: JM Smucker's Earnings
Via Benzinga
Analyst Expectations for JM Smucker's Future
Via Benzinga
Stock Futures Slide, Crypto Hype Pauses: Moody's Bearish China Outlook Sparks Risk Off
Tuesday is shaping up to be a risk-off session, with futures trading in the red in premarket trading, while the dollar and Treasuries are the only major asset classes in the green. 
Via Benzinga
Earnings Scheduled For December 5, 2023
Companies Reporting Before The Bell • Core & Main (NYSE:CNM) is expected to report quarterly earnings at $0.69 per share on revenue of $1.83 billion. 
Via Benzinga
JM Smucker, AutoZone And 3 Stocks To Watch Heading Into Tuesday
With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Investor Sentiment Improves Further; Fear & Greed Index Remains In 'Greed' Zone
The CNN Money Fear and Greed index showed further improvement in overall market sentiment, but the index remained in the "Greed" zone on Monday. U.S. stocks closed lower on Monday after the S&P 500... 
Via Benzinga
Smucker Gears Up For Q2 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
The J. M. Smucker Company (NYSE: SJM) is projected to release financial results for its second quarter fiscal 2024, before the opening bell on Dec. 5, 2023. 
Via Benzinga
3 stocking stuffers you can buy for yourself
These low-beta, deep-value high-yielding stocks are perfect stocking stuffers, even if you buy them for yourself. Rebound is expected in 2024. 
Via MarketBeat
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
3 undervalued food stocks to be grateful for this holiday season
With inflation subsiding and interest rates potentially soon to follow, 2024 could be a very strong year for value stocks. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
3 Stocks To Buy For Thanksgiving 2023
The Thanksgiving week is an opportune time for investors to reassess their stock portfolios for next year. 
Via Talk Markets
3 intriguing late-week earnings plays for short-term traders
These consumer-facing companies slated to provide Q3 results and Q4 guidance later this week may present bullish stock and options trading opportunities. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page 
Via Benzinga
3 Low-Beta Stocks That Promise Steady Upside Potential
Dive into the stability of low-beta stocks and their potential to shield investors from market upheavals amidst the uncertainty. 
Via InvestorPlace
Top Consumer Staples Aristocrats To Buy Amid Recent Market Volatility
Among the conversation of stocks to consider during the market downturn, there's opportunity brewing on the dividend aristocrats list. The consumer staples sector has heavy representation on the... 
Via Talk Markets
Top 4 Defensive Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Food and Beverage Stocks Look Appetizing After Ozempic Selloff
Investors should brush off Ozempic selloff fears and dive into tasty food and beverage stocks that have been oversold in 2023. 
Via InvestorPlace
Adobe, J.M. Smucker And More On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named Consumer Staples Select Sector SPDR Fund (NYSE: XLP) 
Via Benzinga
Will Higher Ozempic Use Mean Slimmed-Down Food Sales?
Novo Nordisk's Ozempic, a weight loss drug, is making waves in the food industry, raising concerns about its effect on sales of calorie-laden products. 
Via MarketBeat
3 Ways To Invest In Coffee, Other Than Drinking It
Investing in coffee while tipping the risk/reward scale in your favor has never been easier, use these data-driven strategies to invest like a true professional 
Via MarketBeat
Topics ETFs Economy
Exposures Economy
Snacks In The Ozempic Era: Food, Beverage Stocks Crash With Weight Loss Drugs On The Rise
Food and beverage stocks endure their toughest week since May 2022, driven by concerns over weight-loss drugs and shifting consumer behavior. 
Via Benzinga
Big Pharma's Weight Loss Drugs Vs. Snacking Industry: Who Will Prevail?
The rising prevalence of obesity and diabetes drugs like Novo Nordisk A/S's (NYSE: NVO) Wegovy and Ozempic is triggering concerns among investors about the future of the snacking industry.  
Via Benzinga
Ticking Time Bombs: 3 Value Stocks to Dump Before the Damage Is Done
Steer clear of these value stocks whose share prices are being dragged lower by some fundamental problems of the companies they represent. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Monday
  On Monday, 369 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 112 companies set new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.